{"id":5646,"date":"2024-02-07T09:10:31","date_gmt":"2024-02-07T15:10:31","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5646"},"modified":"2025-06-27T11:22:09","modified_gmt":"2025-06-27T16:22:09","slug":"nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001\u7b2c47\u56de\u9ec4\u6591\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u3067\u767a\u8868"},"content":{"rendered":"<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<h1><\/h1>\n<\/div>\n<\/div>\n<article class=\"news-release inline-gallery-template\">\n<section class=\"release-body container\">\n<div class=\"row\">\n<div class=\"col-lg-10 col-lg-offset-1\">\n<p><strong>\u30c6\u30ad\u30b5\u30b9\u5dde\u30c0\u30e9\u30b9<\/strong> (2024 \u5e74 2 \u6708 7 \u65e5) \u2014 <a href=\"https:\/\/nanostherapeutics.com\/ja\/\">\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3059\u308b\u81e8\u5e8a\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306f\u672c\u65e5\u3001\u30d3\u30af\u30bf\u30fc\u30fb\u30b4\u30f3\u30b6\u30ec\u30b9\u535a\u58eb\u304c\u8b1b\u6f14\u3059\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002 <a href=\"https:\/\/www.xcdsystem.com\/maculasociety\/program\/hDy5ljm\/index.cfm\">\u7b2c47\u56de\u9ec4\u6591\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a<\/a>, 2\u67087\u65e5\u304b\u308910\u65e5\u307e\u3067\u3001\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d1\u30fc\u30e0\u30b9\u30d7\u30ea\u30f3\u30b0\u30b9\u306e\u30e9\u30fb\u30ad\u30f3\u30bf\u30fb\u30ea\u30be\u30fc\u30c8\uff06\u30af\u30e9\u30d6\u3067\u958b\u50ac\u3055\u308c\u307e\u3059\u3002\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n<p><strong>\u30bf\u30a4\u30c8\u30eb\uff1a<\/strong> MCO-010 \u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u3092\u6cbb\u7642\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7642\u6cd5\uff1a\u7b2c 2a \u76f8 STARLIGHT \u81e8\u5e8a\u8a66\u9a13\u306e 48 \u9031\u76ee\u307e\u3067\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027<br \/>\n<strong>\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb: <\/strong>\u907a\u4f1d\u6027\u7db2\u819c\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc I (\u6cbb\u7642\u8a66\u9a13)<br \/>\n<strong>\u65e5\u4ed8\uff1a\u00a0<\/strong>2024 \u5e74 2 \u6708 7 \u65e5<br \/>\n<strong>\u6642\u9593\uff1a\u00a0<\/strong>\u5348\u5f8c 6 \u6642 18 \u5206\uff5e\u5348\u5f8c 6 \u6642 25 \u5206\uff08\u592a\u5e73\u6d0b\u6642\u9593\uff09<br \/>\n<strong>\u4f4d\u7f6e\uff1a\u00a0<\/strong>\u30e1\u30a4\u30f3\u30db\u30fc\u30eb<br \/>\n<strong>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/strong>Victor Gonzalez \u535a\u58eb\u3001\u30d0\u30ec\u30fc\u7db2\u819c\u7814\u7a76\u6240\u3001\u30c6\u30ad\u30b5\u30b9\u5dde\u30de\u30c3\u30ab\u30ec\u30f3<\/p>\n<p>\u30b4\u30f3\u30b6\u30ec\u30b9\u535a\u58eb\u306f\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u4e2d\u306b\u3001STARLIGHT \u304b\u3089\u306e\u8a66\u9a13\u30c7\u30b6\u30a4\u30f3\u3068 48 \u9031\u9593\u306e\u30c7\u30fc\u30bf\u306e\u6982\u8981\u3092\u8aac\u660e\u3057\u307e\u3059 (<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05417126?term=nanoscope&draw=2&rank=3\">NCT05417126<\/a>\uff09\u3001\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u306b\u3088\u308b\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u306b\u5bfe\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u306e\u6700\u521d\u306e\u81e8\u5e8a\u7814\u7a76\u3002\u30b4\u30f3\u30b6\u30ec\u30b9\u535a\u58eb\u306f\u3001MCO-010 \u3092 1 \u56de\u785d\u5b50\u4f53\u5185\u306b\u6ce8\u5c04\u3057\u305f\u5f8c\u306e\u3001ETDRS \u30c1\u30e3\u30fc\u30c8\u3067\u6e2c\u5b9a\u3057\u305f STARLIGHT \u60a3\u8005\u306e\u6700\u9ad8\u77ef\u6b63\u8996\u529b (BCVA) \u306e\u6539\u5584\u306b\u3064\u3044\u3066\u8aac\u660e\u3057\u307e\u3059\u3002\u30b4\u30f3\u30b6\u30ec\u30b9\u535a\u58eb\u306f\u307e\u305f\u3001\u30d5\u30a7\u30fc\u30ba 3 \u306b\u9032\u3080\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8 \u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u4eca\u5f8c\u306e\u81e8\u5e8a\u958b\u767a\u306b\u3001STARLIGHT \u306e\u7d50\u679c\u304c\u3069\u306e\u3088\u3046\u306b\u5f79\u7acb\u3064\u304b\u306b\u3064\u3044\u3066\u306e\u8003\u3048\u3092\u5171\u6709\u3057\u307e\u3059\u3002<\/p>\n<p><strong>STARLIGHT \u81e8\u5e8a\u8a66\u9a13\u306e\u4e3b\u306a\u7d50\u679c<\/strong><\/p>\n<ul>\n<li>MCO-010 \u306f\u5fcd\u5bb9\u6027\u304c\u9ad8\u304f\u3001\u91cd\u7be4\u306a\u6709\u5bb3\u4e8b\u8c61 (SAE) \u306f 48 \u9031\u9593\u7dad\u6301\u3055\u308c\u307e\u3057\u305f<\/li>\n<li>\u4e3b\u306b\u9ec4\u6591\u75be\u60a3\u3092\u60a3\u3046\u60a3\u8005\u306f\u3001BCVA \u306b\u304a\u3044\u3066\u81e8\u5e8a\u7684\u306b\u610f\u5473\u306e\u3042\u308b\u6539\u5584\u3092\u7d4c\u9a13\u3057\u307e\u3057\u305f<\/li>\n<li>\u8996\u91ce\u304a\u3088\u3073\u60a3\u8005\u5831\u544a\u30a2\u30a6\u30c8\u30ab\u30e0\uff08\u8aad\u66f8\u80fd\u529b\u3001\u8272\u899a\u30fb\u30b3\u30f3\u30c8\u30e9\u30b9\u30c8\uff09\u306b\u304a\u3044\u3066\u6539\u5584\u304c\u8a8d\u3081\u3089\u308c\u305f\u3002<\/li>\n<\/ul>\n<p><strong>\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u306b\u3064\u3044\u3066<\/strong><strong><br \/>\n<\/strong>\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u306f\u3001\u9ec4\u6591\u5185\u306e\u8102\u80aa\u6c88\u7740\u306b\u3088\u3063\u3066\u5f15\u304d\u8d77\u3053\u3055\u308c\u308b\u307e\u308c\u306a\u907a\u4f1d\u6027\u306e\u773c\u75be\u60a3\u3067\u3001\u4e2d\u5fc3\u8996\u91ce\u306e\u55aa\u5931\u306b\u3064\u306a\u304c\u308a\u307e\u3059\u3002\u7c73\u56fd\u3067\u306f\u7d04 8,000 \uff5e 10,000 \u4eba\u306e\u60a3\u8005\u304c\u7f79\u60a3\u3057\u3066\u304a\u308a\u3001\u591a\u304f\u306e\u5834\u5408\u3001\u5c0f\u5150\u671f\u307e\u305f\u306f\u9752\u5e74\u671f\u306b\u75c7\u72b6\u304c\u59cb\u307e\u308a\u307e\u3059\u3002\u73fe\u5728\u3001FDA \u304c\u627f\u8a8d\u3057\u305f\u6cbb\u7642\u6cd5\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<p><strong>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066<br \/>\n<\/strong>Nanoscope Therapeutics \u306f\u3001\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306b\u3088\u3063\u3066\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u305b\u305a\u8996\u529b\u3092\u56de\u5fa9\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u4e3b\u529b\u8cc7\u7523\u3067\u3042\u308b MCO-010 \u306f\u3001\u7c73\u56fd\u3067\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f RESTORE \u7b2c 2b \u76f8\u591a\u65bd\u8a2d\u7121\u4f5c\u70ba\u5316\u4e8c\u91cd\u30de\u30b9\u30af\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u6700\u8fd1\u5831\u544a\u3057\u307e\u3057\u305f (<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04945772?term=Nanoscope&draw=2\">NCT04945772<\/a>\uff09\u3002\u540c\u793e\u306f\u6700\u8fd1\u3001\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f MCO-010 \u7642\u6cd5\u306e\u7b2c 2 \u76f8 STARLIGHT \u8a66\u9a13\u3082\u5b8c\u4e86\u3057\u307e\u3057\u305f (<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05417126?term=nanoscope&draw=2&rank=3\">NCT05417126<\/a>\uff09\u3002 MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u306e\u4e21\u65b9\u306b\u5bfe\u3057\u3066FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u304a\u3088\u3073FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u7406\u7684\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u30ec\u30fc\u30b6\u30fc\u306b\u3088\u308b MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<p><strong>\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/strong><br \/>\n\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba<br \/>\n212-600-1902<br \/>\n<a href=\"mailto:PR@nanostherapeutics.com\">PR@nanostherapeutics.com<\/a><\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"<p>Dallas, TX (February 7, 2024) \u2014 Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced that Dr. Victor Gonzalez will present at the 47th Annual Macula Society Meeting, taking place from Feb 7-10 at the La Quinta Resort &#038; Club in Palm Springs, California. Presentation details are as follows: Title: MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy Through Week 48 in the Phase 2a STARLIGHT Clinical Trial Session Title: Inherited Retinal Dystrophy I (Treatment Trials) Date:\u00a0February 7, 2024 Time:\u00a06:18 PM-6:25 PM PT Location:\u00a0Main Hall Presenter:\u00a0Dr. Victor Gonzalez, Valley Retina Institute, McAllen, TX During his presentation, Dr. Gonzalez will outline the [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5648,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5646","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics to Present at 47th Annual Macula Society Meeting - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics to Present at 47th Annual Macula Society Meeting - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-07T15:10:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:22:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_MaculaSociety2024.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_MaculaSociety2024.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics to Present at 47th Annual Macula Society Meeting\",\"datePublished\":\"2024-02-07T15:10:31+00:00\",\"dateModified\":\"2025-06-27T16:22:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/\"},\"wordCount\":394,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/NSCOPE_LI_MaculaSociety2024.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/\",\"name\":\"Nanoscope Therapeutics to Present at 47th Annual Macula Society Meeting - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/NSCOPE_LI_MaculaSociety2024.jpg\",\"datePublished\":\"2024-02-07T15:10:31+00:00\",\"dateModified\":\"2025-06-27T16:22:09+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/NSCOPE_LI_MaculaSociety2024.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/NSCOPE_LI_MaculaSociety2024.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/07\\\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics to Present at 47th Annual Macula Society Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7b2c47\u56de\u9ec4\u6591\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u3067\u767a\u8868\u3078 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics to Present at 47th Annual Macula Society Meeting - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-02-07T15:10:31+00:00","article_modified_time":"2025-06-27T16:22:09+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_MaculaSociety2024.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_MaculaSociety2024.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics to Present at 47th Annual Macula Society Meeting","datePublished":"2024-02-07T15:10:31+00:00","dateModified":"2025-06-27T16:22:09+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/"},"wordCount":394,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_MaculaSociety2024.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/","url":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7b2c47\u56de\u9ec4\u6591\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u3067\u767a\u8868\u3078 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_MaculaSociety2024.jpg","datePublished":"2024-02-07T15:10:31+00:00","dateModified":"2025-06-27T16:22:09+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_MaculaSociety2024.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_MaculaSociety2024.jpg","width":1200,"height":627},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/02\/07\/nanoscope-therapeutics-to-present-at-47th-annual-macula-society-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics to Present at 47th Annual Macula Society Meeting"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5646"}],"version-history":[{"count":4,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5646\/revisions"}],"predecessor-version":[{"id":9055,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5646\/revisions\/9055"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5648"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}